These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32319370)
1. [Ikaros Family Zinc Finger 1 Mutation Is an Adverse Prognostic Factor for Patients with Adult B-Cell Acute Lymphoblastic Leukemia]. Tang SH; Lu Y; Zhang PS; Liu XH; DU XH; Chen D; Pei RZ; Tang XW Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):405-410. PubMed ID: 32319370 [TBL] [Abstract][Full Text] [Related]
2. Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes. Tang S; Shen H; Qu C; Dai H; Zhu X; Xue S; Ding Z; Lu J; Wu D; Tang X Bone Marrow Transplant; 2019 Feb; 54(2):236-243. PubMed ID: 29942002 [TBL] [Abstract][Full Text] [Related]
3. [Ikaros family zinc finger 1 mutation is a poor prognostic factor for adult Philadelphia chromosome positive acute lymphoblastic leukemia]. Tang SH; Lu Y; Zhang PS; Liu XH; Du XH; Chen D; Li SY; Cao JJ; Chen LG; Le J; Qian SY; Hong YW; Pei RZ Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):301-306. PubMed ID: 30917424 [No Abstract] [Full Text] [Related]
4. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA Br J Haematol; 2015 Feb; 168(3):395-404. PubMed ID: 25312094 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia. Yao QM; Liu KY; Gale RP; Jiang B; Liu YR; Jiang Q; Jiang H; Zhang XH; Zhang MJ; Chen SS; Huang XJ; Xu LP; Ruan GR BMC Cancer; 2016 Apr; 16():269. PubMed ID: 27067989 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT. Giebel S; Labopin M; Socié G; Beauvais D; Klein S; Wagner-Drouet EM; Blaise D; Nguyen-Quoc S; Bourhis JH; Thiebaut A; Labussière-Wallet H; Charbonnier A; Berceanu A; Diez-Martin JL; Fegueux N; Esteve J; Nagler A; Mohty M Bone Marrow Transplant; 2021 May; 56(5):1047-1055. PubMed ID: 33235351 [TBL] [Abstract][Full Text] [Related]
7. [Significance of ikaros family zinc finger 1 deletion in pediatric B-acute lymphoblastic leukemia without reproducible cytogenetic abnormalities]. Liu X; Zhang L; Zou Y; Chang L; Wei W; Ruan M; Chen Y; Yang W; Chen X; Guo Y; Wang S; Liu T; Zhang J; Liu F; Qi B; An W; Zhu X Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):126-30. PubMed ID: 26875463 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance of IKZF1 gene deletions in patients with B-cell acute lymphoblastic leukemia]. Tang BQ; Cai ZH; Lin DN; Wang ZX; Liang XJ; Fan ZP; Huang F; Liu QF; Zhou HS Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):235-240. PubMed ID: 35405782 [No Abstract] [Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20-a very high-risk subtype in B-cell acute lymphoblastic leukemia. Tang B; Cai Z; Wang Z; Lin D; He X; Li Q; Liang X; Huang K; Zhou X; Lin R; Xu N; Fan Z; Huang F; Sun J; Liu X; Liu Q; Zhou H Bone Marrow Transplant; 2022 Dec; 57(12):1751-1757. PubMed ID: 36056210 [TBL] [Abstract][Full Text] [Related]
10. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. Asai D; Imamura T; Suenobu S; Saito A; Hasegawa D; Deguchi T; Hashii Y; Matsumoto K; Kawasaki H; Hori H; Iguchi A; Kosaka Y; Kato K; Horibe K; Yumura-Yagi K; Hara J; Oda M; Cancer Med; 2013 Jun; 2(3):412-9. PubMed ID: 23930217 [TBL] [Abstract][Full Text] [Related]
11. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance. Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG-2016 study. Lin S; Liao N; Li X; Yang L; He YY; Tang YL; Wan WQ; Jia W; Zhang YJ; Kong Q; Long X; Lan X; Ling YY; Lin D; Zhang XL; Wen C; Li CK; Xu HG Eur J Haematol; 2024 Sep; 113(3):357-370. PubMed ID: 38847134 [TBL] [Abstract][Full Text] [Related]
13. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature. Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040 [TBL] [Abstract][Full Text] [Related]
14. [Allogeneic hematopoietic stem cell transplantation for treatment of Philadelphia chromosome positive acute lymphoblastic leukemia]. Xu LP; Huang XJ; Liu KY; Chen H; Liu DH; Zhang YC; Chen YH; Han W; Gao ZY; Lu DP Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):231-5. PubMed ID: 15968308 [TBL] [Abstract][Full Text] [Related]
15. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia]. Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597 [No Abstract] [Full Text] [Related]
16. [The effect of TP53 mutations on the clinical outcomes of Ph-negative B-acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation]. Cao XY; Zhang Y; Liu DY; Zhang JP; Wei ZJ; Xiong M; Sun RJ; Lu Y; Zhou JR; Zhao YL; Ma W; Zhang W Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):908-914. PubMed ID: 33333693 [No Abstract] [Full Text] [Related]
17. Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis. Zhang W; Kuang P; Li H; Wang F; Wang Y Ann Hematol; 2017 Feb; 96(2):215-225. PubMed ID: 27815723 [TBL] [Abstract][Full Text] [Related]
18. [Effect of increasing the intensity of chemotherapy on the prognosis of acute lymphoblastic leukemia in children with IKZF1 deletion]. Zheng YZ; Li J; LE SH; Zheng H; Hua XL; Chen ZS; Hu JD Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jul; 21(7):690-695. PubMed ID: 31315770 [TBL] [Abstract][Full Text] [Related]
19. Loss-of-function but not dominant-negative intragenic Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia. Wang Y; Chen G; Cao R; Li J; He L; Guo X; Liang J; Shi P; Zhou Y; Xu B Pharmacogenomics; 2017 Jan; 18(1):77-84. PubMed ID: 27967319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]